Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma-Reference-Cited by-同舟云学术

Spontaneous Regression and Complete Response to Immune Checkpoint Blockade in a Case of High-Grade Neuroendocrine Carcinoma

Published:2020-11 Issue:4 Volume: Page:1006-1011
ISSN:2473-4284
Container-title:JCO Precision Oncology
language:en
Short-container-title:JCO Precision Oncology

Author:

Raufi Alexander G.¹²,May Michael²,Greendyk Richard A.²,Iuga Alina³,Ahmed Firas⁴,Mansukhani Mahesh³,Manji Gulam A.²

Affiliation:

1. Division of Hematology-Oncology, Lifespan Cancer Institute, Warren-Alpert Medical School of Brown University, Providence, RI

2. Division of Hematology and Oncology, Columbia University Irving Medical Center, and New York Presbyterian Hospital, Herbert Irving Pavilion, New York, NY

3. Department of Pathology, Columbia University Medical Center, New York, NY

4. Department of Radiology, Columbia University Medical Center, New York, NY

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Cancer Research,Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/PO.20.00103

Reference31 articles.

1. Understanding the role of PD-L1/PD1 pathway blockade and autophagy in cancer therapy

2. PD-1/PD-L1 inhibitors

3. A Phase II Basket Trial of Dual Anti–CTLA-4 and Anti–PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors

4. Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States

5. Clinical features of large cell neuroendocrine carcinoma: a population-based overview

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Fatal overwhelming post-splenectomy infection in a patient with metastatic angiosarcoma treated with immunotherapy;Frontiers in Immunology;2024-05-08

2. Artificial Intelligence-Powered Whole-Slide Image Analyzer Reveals a Distinctive Distribution of Tumor-Infiltrating Lymphocytes in Neuroendocrine Neoplasms;Diagnostics;2022-09-27

3. Elevated Flt3L Predicts Long-Term Survival in Patients with High-Grade Gastroenteropancreatic Neuroendocrine Neoplasms;Cancers;2021-09-04